Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAID
Aurélien Amiot(Université Paris-Est Créteil), Pauline Wils(Hôpital Claude Huriez), David Laharie(Université de Bordeaux), Ludovic Caillo(Université de Nîmes), Florian Poullenot(Bordeaux Population Health), Xavier Tréton(Hôpital Beaujon), Anne Bourrier, Cathérine Reenaers(Centre Hospitalier Universitaire de Liège), Stéphane Paul(Université Claude Bernard Lyon 1), Laurent Peyrin‐Biroulet(Délégation Centre-Est), Véred Abitbol(Hôpital Cochin), Mélanie Serrero(Assistance Publique Hôpitaux de Marseille), Bénédicte Caron, Guillaume Bouguen(Inserm), Mathurin Fuméry(Centre Hospitalier Universitaire Amiens-Picardie), Anthony Buisson(Centre Hospitalier Universitaire de Clermont-Ferrand), Lucas Guillo, Lucine Vuitton(Centre Hospitalier Universitaire de Besançon), Cyrielle Gilletta, Georgia Malamut(Délégation Paris 5), Amélie Biron, Maria Nachury(Centre Hospitalier Universitaire de Lille), Catherine Le Berre(Inserm), Nicolas Mathieu(Centre National de la Recherche Scientifique), Mathieu Uzzan, Jean‐Marc Gornet(Hôpital Saint-Louis), Arnaud Bourreille, Edouard Louis, Laurianne Plastaras(Hôpital Pasteur), Maëva Charkaoui, Marion Simon(Institute Mutualiste Montsouris), Stéphanie Viennot(Centre Hospitalier Universitaire de Besançon), Alain Attar(Hôpital Saint Lazare), Stéphane Nancey
Cited by 12
Related Papers
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Potential of fecal microbiota for early‐stage detection of colorectal cancer
|Molecular Systems Biology|2014|1.4k
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2019|1.2k
Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines
|Journal of Crohn s and Colitis|2013|669